Skip to main content
. 2017 Dec 20;9(5):5834–5847. doi: 10.18632/oncotarget.23533

Figure 3. In vitro expression levels of CD39 and CD73 on B cells.

Figure 3

Human B cells (precultured with IL-4, CD40L, and hemagglutinin) from healthy donors were separated as described and cultured in the presence of therapeutic concentrations of cytostatic drugs in RPMI medium. (A) Data are means ± standard deviation determined for all CD19+ B cells obtained from at least 3 normal donors. (B) Box plots showing mean fluorescence intensity of CD39 and CD73 in B cells precultured with 5 µg/mL of one cytostatic drug, respectively.